Vyome Holdings, Inc (HIND) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US92943X1046
Vyome Holdings, Inc financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 319,714.00 USD |
| Gross profit | 218,771.00 USD |
| Operating income | -10.45 m USD |
| EBIT | -10.33 m USD |
| Net income | -10.26 m USD |
| Diluted EPS – continuing operations | -4.86 USD |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Vyome Holdings, Inc
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5'-monophosphate dehydrogenase enzyme inhibitor to treat immunoinflammatory conditions of the eye; and VB-1953, which is in phase 2 clinical stage for the treatment of inflammatory acne. In addition, the company develops antifungal products using the molecular replacement therapy (MRT) platform. It has a collaboration and license agreement with Sun Pharma Laboratories Limited to develop and commercialize next-generation antifungal products. The company is based in Cambridge, Massachusetts.
More stocks
- GUIDED THERAPEUTICS INC (GTHP)
- INTRUSION INC (INTZ)
- PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. (PAXH)
- EWSB Bancorp, Inc. /MD/ (EWSB)
- Gyrodyne, LLC (GYRO)
- Granite Point Mortgage Trust Inc. (GPMT)
- LISATA THERAPEUTICS, INC. (LSTA)
- PAVmed Inc. (PAVM)
- Mobiquity Technologies, Inc. (MOBQ)
- MedApp S.A (MDA.WA)
- Rise Gold Corp. (RYES)
- Foxx Development Holdings Inc. (FOXX)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.